C07D 239/00
Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
C07D239/00 (Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings) appears on 11,376 US grants and 10,041 published applications in this corpus.
Search patents in C07D- Granted patents
- 11,376
- Published applications
- 10,041
- Assignees
- 3,292
- Inventors
- 27,409
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 139 | 0 |
| 1977 | 100 | 0 |
| 1978 | 108 | 0 |
| 1979 | 89 | 0 |
| 1980 | 111 | 0 |
| 1981 | 121 | 0 |
| 1982 | 100 | 0 |
| 1983 | 99 | 0 |
| 1984 | 116 | 0 |
| 1985 | 144 | 0 |
| 1986 | 146 | 0 |
| 1987 | 153 | 0 |
| 1988 | 149 | 0 |
| 1989 | 164 | 0 |
| 1990 | 169 | 0 |
| 1991 | 159 | 0 |
| 1992 | 176 | 0 |
| 1993 | 197 | 0 |
| 1994 | 197 | 0 |
| 1995 | 197 | 0 |
| 1996 | 181 | 0 |
| 1997 | 227 | 0 |
| 1998 | 258 | 0 |
| 1999 | 225 | 0 |
| 2000 | 207 | 0 |
| 2001 | 253 | 49 |
| 2002 | 282 | 252 |
| 2003 | 227 | 357 |
| 2004 | 205 | 438 |
| 2005 | 183 | 451 |
| 2006 | 251 | 384 |
| 2007 | 213 | 382 |
| 2008 | 199 | 409 |
| 2009 | 239 | 456 |
| 2010 | 307 | 525 |
| 2011 | 292 | 443 |
| 2012 | 360 | 407 |
| 2013 | 412 | 420 |
| 2014 | 427 | 483 |
| 2015 | 450 | 513 |
| 2016 | 379 | 481 |
| 2017 | 450 | 475 |
| 2018 | 370 | 414 |
| 2019 | 349 | 385 |
| 2020 | 333 | 416 |
| 2021 | 246 | 362 |
| 2022 | 264 | 366 |
| 2023 | 202 | 399 |
| 2024 | 206 | 335 |
| 2025 | 201 | 252 |
| 2026 | 144 | 187 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Crystalline forms of a BTK inhibitor6 Oct 2026US 12,751,949 B2Novartis AG
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Membrane-active anti-bacterial compounds and uses thereof29 Sep 2026US 12,747,213 B2Regents of the University of Minnesota
- Probenecid compounds for the treatment of inflammasome-mediated lung disease8 Oct 2026US 2026/0308131 A1Bacainn Biotherapeutics, Ltd.
- Estrogen-receptor modulator and use thereof8 Oct 2026US 2026/0308139 A1Jiangsu Vcare PharmaTech Co., Ltd.
- Neuroactive androgen receptor modulators and use thereof1 Oct 2026US 2026/0294908 A1ENDOCHEM PHARMACEUTICALS (BEIJING) CO., LTD. Beijing
- An organic compound and an organic electroluminescent device using the same1 Oct 2026US 2026/0297034 A1Solus Advanced Materials Co., Ltd.
- Protein kinase inhibitors and uses thereof1 Oct 2026US 2026/0297035 A1DELiver Therapeutics, Inc.
Most cited
By later US patents
- Pyrimidine, cyanoguanidines as K-channel blockers1,019US 5,633,374 AThe Upjohn Company · 1997
- Pyrimidine derivatives for labeled binding partners639US 5,502,177 AGilead Sciences, Inc. · 1996
- Pyrimidine derivatives488US 6,005,096 AGilead Sciences, Inc. · 1999
- Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates468US 5,700,920 ANovartis AG · 1997
- Pyrimidine derivatives for labeled binding partners456US 5,763,588 AGilead Sciences, Inc. · 1998